PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+18.39%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$511M
AUM Growth
+$511M
(+39%)
Cap. Flow
+$54.2M
Cap. Flow
% of AUM
10.61%
Top 10 Holdings %
Top 10 Hldgs %
44.63%
Holding
131
New
33
Increased
21
Reduced
23
Closed
15
Top Buys
| 1 |
AtriCure
ATRC
|
$13.3M |
| 2 |
LHCG
LHC Group LLC
LHCG
|
$11.6M |
| 3 |
CONMED
CNMD
|
$7.91M |
| 4 |
LivaNova
LIVN
|
$7.29M |
| 5 |
Immunovant
IMVT
|
$6.59M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
$8.07M |
| 2 |
Adaptive Biotechnologies
ADPT
|
$6.21M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$5.48M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$5.36M |
| 5 |
DexCom
DXCM
|
$5.15M |
Sector Composition
| 1 | Healthcare | 78.26% |
| 2 | Industrials | 2.82% |
| 3 | Energy | 2.26% |
| 4 | Consumer Discretionary | 0.62% |
| 5 | Consumer Staples | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
1
DELISTED
NanoString Technologies, Inc.
NSTG
| $31.1M | 2.99% | 1,060,731 +149,478 | +16% | +$4.39M |
|
|
2
AtriCure
ATRC
$1.84B
| $30.8M | 2.96% | 685,273 +296,279 | +76% | +$13.3M |
|
3
Inspire Medical Systems
INSP
$2.77B
| $29.3M | 2.82% | 337,016 -27,964 | -8% | -$2.43M |
|
4
ICU Medical
ICUI
$3.15B
| $24.7M | 2.38% | 134,251 +7,467 | +6% | +$1.38M |
|
|
ALXN
5
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $23M | 2.21% | 204,696 -3,300 | -2% | -$370K |
|
|
6
STAAR Surgical
STAA
$1.36B
| $22M | 2.12% | 357,780 -131,170 | -27% | -$8.07M |
|
|
INOV
7
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $20.2M | 1.94% | 1,047,216 -56,824 | -5% | -$1.09M |
|
8
Establishment Labs
ESTA
$1.2B
| $17.7M | 1.7% | 944,958 +66,731 | +8% | +$1.25M |
|
|
VRAY
9
DELISTED
ViewRay, Inc.
VRAY
| $15.3M | 1.47% | 6,842,954 -61,674 | -0.9% | -$138K |
|
|
XENT
10
DELISTED
Intersect ENT, Inc
XENT
| $13.9M | 1.33% | 1,024,374 +342,509 | +50% | +$4.64M |
|
|
LHCG
11
DELISTED
LHC Group LLC
LHCG
| $11.6M | 1.11% | +66,359 | New | +$11.6M |
|
|
IMDX
12
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $11.4M | 1.1% | 5,983,724 +405,441 | +7% | +$774K |
|
|
IVC
13
DELISTED
Invacare Corporation
IVC
| $10.2M | 0.98% | 1,595,609 -12,237 | -0.8% | -$77.9K |
|
|
14
DexCom
DXCM
$29.5B
| $9.93M | 0.95% | 24,483 -12,700 | -34% | -$5.15M |
|
|
PROF
15
Profound Medical
PROF
$134M
| $9.72M | 0.93% | 573,556 +31,300 | +6% | +$530K |
|
|
RCM
16
DELISTED
R1 RCM Inc. Common Stock
RCM
| $9.65M | 0.93% | 865,844 -208,099 | -19% | -$2.32M |
|
|
QTNT
17
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $9.4M | 0.9% | 1,270,434 -410,207 | -24% | -$3.04M |
|
18
Zimmer Biomet
ZBH
$21B
| $8.91M | 0.86% | 74,652 -36,200 | -33% | -$4.32M |
|
|
19
CONMED
CNMD
$1.68B
| $7.91M | 0.76% | +109,900 | New | +$7.91M |
|
20
SI-BONE Inc
SIBN
$719M
| $7.55M | 0.73% | 473,703 -42,773 | -8% | -$682K |
|
21
OrthoPediatrics
KIDS
$536M
| $7.53M | 0.72% | 172,113 +23,600 | +16% | +$1.03M |
|
|
22
LivaNova
LIVN
$3.08B
| $7.29M | 0.7% | +151,473 | New | +$7.29M |
|
|
23
Immunovant
IMVT
$2.56B
| $6.59M | 0.63% | +270,806 | New | +$6.59M |
|
24
Boston Scientific
BSX
$156B
| $6.44M | 0.62% | 183,500 +58,500 | +47% | +$2.05M |
|
|
DMTK
25
DELISTED
DermTech, Inc. Common Stock
DMTK
| $6.23M | 0.6% | 471,143 +162,227 | +53% | +$2.15M |
|